Literature DB >> 8005182

Central effects of repeated administration of atenolol and captopril in healthy volunteers.

D G McDevitt1, D Currie, A N Nicholson, N A Wright, M B Zetlein.   

Abstract

The central effects of atenolol (50 mg tds) and captopril (50 mg tds) ingested for a period of seven days were studied in ten healthy volunteers. A placebo and two active control drugs, methyldopa (250 mg tds) and oxazepam (10 mg), were included in the design. Oxazepam was ingested on the seventh day only, with a placebo being taken on the preceding six days. On the seventh day, central effects of the drugs were tested at 10.00-11.00 h (session 1), immediately before the subjects' last dose of each drug and at 2.5-3.5 h after the final dose of each drug (1330-1430 h, session 2). Performance was assessed using digit symbol substitution, continuous attention, letter cancellation, choice reaction time, finger tapping, immediate and short-term memory, critical flicker fusion and two flash fusion. Subjects assessed their mood and well-being on a series of 12 visual analogue scales. Recordings of the EEG and body sway were carried out. Neither atenolol nor captopril altered performance at any of the skills tested. There were no effects on subjectively assessed alertness or mood with captopril, while atenolol significantly increased wakefulness in session 2 and when the two sessions were meaned. Similarly, captopril did not modify body sway, while with atenolol there was a significant decrease in activity in the frequency range 1.0-2.75 Hz from session 1 to session 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005182     DOI: 10.1007/BF00195911

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

2.  Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.

Authors:  A N Nicholson; N A Wright; M B Zetlein; D Currie; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

3.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

4.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. II. Electroencephalogram and body sway.

Authors:  A N Nicholson; N A Wright; M B Zetlein; D Currie; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

5.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

6.  High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.

Authors:  H Winkler; W Ried; B Lemmer
Journal:  J Chromatogr       Date:  1982-03-12

7.  High-performance liquid chromatographic determination of metoprolol in plasma.

Authors:  M T Rosseel; F M Belpaire; I Bekaert; M G Bogaert
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

  7 in total
  1 in total

1.  Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.

Authors:  S D Hutcheon; N D Gillespie; I K Crombie; A D Struthers; M E T McMurdo
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.